PTCY vs ATG in all-HCT2021 Van Bekkum Award - Eolia Brissot

preview_player
Показать описание
EBMT TV met online with Eolia Brissot of San Antoine Hospital, Paris and this year's Van Bekkum Award at the 47th Annual Meeting of the EBMT. She explains her award-winning work-study, Post-transplantation Cyclophosphamide versus Antithymocyte globulin after Ric regimen allo-HCT: first analysis of a prospective randomized multicenter trial in recipients of 10/10 matched donors.
  1. WebsEdgeMedicine
Рекомендации по теме
PTCY vs ATG 0:03:51

PTCY vs ATG in all-HCT2021 Van Bekkum Award - Eolia Brissot

PTCy vs ATG 0:03:50

PTCy vs ATG in ALL in haploidentical, unrelated and sibling donor transplantation

ATG vs PTCy 0:03:41

ATG vs PTCy as GvHD prophylaxis in non-myeloablative MUD alloHSCT

PTCy versus ATG 0:03:36

PTCy versus ATG as haploidentical transplant prophylaxis

Should we use 0:03:07

Should we use PTCy or ATG as GvHD prophylaxis in haploidentical stem cell transplantation?

The role of 0:02:03

The role of PTCy/MMF/CNI as the standard of care for GvHD prophylaxis in the MUD setting

Cyclophosphamide vs ATG 0:02:49

Cyclophosphamide vs ATG for GvHD prevention in haplo-HSCT for adult ALL

ATG and/or post-Cy 0:04:52

ATG and/or post-Cy for GvHD prophylaxis

Should PTCy be 0:05:25

Should PTCy be used as GvHD prophylaxis in the MUD setting?

Transplantation: antithymocyte globulin 0:02:08

Transplantation: antithymocyte globulin

PTCy/Tac/MMF as the 0:03:23

PTCy/Tac/MMF as the new standard for GVHD prophylaxis in reduced intensity conditioning

PARACHUTE trial: ATG 0:03:23

PARACHUTE trial: ATG in HCST

When would you 0:03:42

When would you favor PTCy over CSA/MTX as GvHD prophylaxis after matched sibling donor HSCT?

Advances in GvHD 0:00:53

Advances in GvHD management and prophylaxis

Post-Transplant Cyclophosphamide and 0:02:52

Post-Transplant Cyclophosphamide and Unmet Needs in GVHD

The use of 0:03:23

The use of post-transplant cyclophosphamide

Factors determining the 0:05:13

Factors determining the effectiveness of treatment with ATG following transplantation

DLI following haploHCT 0:02:33

DLI following haploHCT PTCy relapse

GVHD Outcomes With 0:06:30

GVHD Outcomes With Post-Transplant Cyclophosphamide, Tacrolimus, and... in Stem Cell Transplant

How to select 0:03:11

How to select the optimal GvHD prophylaxis regimen

Post-transplant cyclophosphamide in 0:02:05

Post-transplant cyclophosphamide in chronic GvHD

Predictors for autoimmune 0:03:35

Predictors for autoimmune cytopenias in pediatric allo-HSCT

Post transplantation Cyclophosphamide 0:43:48

Post transplantation Cyclophosphamide Based Graft-versus-Host Disease Prophylaxis

ASCO: Secondary Cytoreductive 0:03:39

ASCO: Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer